Isaac Zacharias - Oct 15, 2021 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Signature
/s/ Wade Estey, as attorney in fact for Isaac Zacharias
Stock symbol
SWAV
Transactions as of
Oct 15, 2021
Transactions value $
-$776,700
Form type
4
Date filed
10/18/2021, 04:55 PM
Previous filing
Sep 16, 2021
Next filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale -$468K -2.42K -4.37% $193.24 53K Oct 15, 2021 Direct F1, F2
transaction SWAV Common Stock Sale -$155K -800 -1.51% $194.17 52.2K Oct 15, 2021 Direct F3
transaction SWAV Common Stock Sale -$67.7K -347 -0.66% $195.18 51.8K Oct 15, 2021 Direct F4
transaction SWAV Common Stock Sale -$59.3K -300 -0.58% $197.78 51.5K Oct 15, 2021 Direct F5
transaction SWAV Common Stock Sale -$25.9K -129 -0.25% $200.69 51.4K Oct 15, 2021 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/14/2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $192.68 to $193.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $193.75 to $194.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $194.89 to $195.55. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.65 to $197.85. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The reported securities were sold at a price of $200.69.